Organon & Co.
NYSE:OGN
14.94 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,582 | 1,607 | 1,622 | 1,598 | 1,519 | 1,608 | 1,538 | 1,485 | 1,537 | 1,585 | 1,567 | 1,604 | 1,600 | 1,595 | 1,506 | 3,177 | 1,613 | 1,526 | 1,780 |
| Cost of Revenue
| 659 | 668 | 665 | 683 | 612 | 640 | 580 | 594 | 551 | 588 | 561 | 599 | 609 | 583 | 591 | 1,814 | 535 | 460 | 538 |
| Gross Profit
| 923 | 939 | 957 | 915 | 907 | 968 | 958 | 891 | 986 | 997 | 1,006 | 1,005 | 991 | 1,012 | 915 | 1,363 | 1,078 | 1,066 | 1,242 |
| Gross Profit Ratio
| 0.583 | 0.584 | 0.59 | 0.573 | 0.597 | 0.602 | 0.623 | 0.6 | 0.642 | 0.629 | 0.642 | 0.627 | 0.619 | 0.634 | 0.608 | 0.429 | 0.668 | 0.699 | 0.698 |
| Reseach & Development Expenses
| 111 | 116 | 112 | 134 | 137 | 128 | 129 | 142 | 127 | 106 | 96 | 189 | 111 | 76 | 67 | 154 | 54 | 51 | 45 |
| General & Administrative Expenses
| 0 | 0 | 0 | 260 | 0 | 0 | 0 | 215 | 0 | 0 | 0 | 245 | 0 | 0 | 0 | 546 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 209 | 0 | 0 | 0 | 255 | 0 | 0 | 0 | 236 | 0 | 0 | 0 | 198 | 0 | 0 | 0 |
| SG&A
| 422 | 437 | 431 | 469 | 538 | 451 | 435 | 470 | 440 | 423 | 371 | 481 | 388 | 416 | 382 | 744 | 321 | 284 | 317 |
| Other Expenses
| 0 | -6 | -3 | -4 | -4 | -1 | -6 | 0 | -4 | 14 | -97 | -99 | -102 | -82 | -2 | -37 | 8 | 11 | -11 |
| Operating Expenses
| 533 | 553 | 543 | 603 | 675 | 579 | 564 | 612 | 567 | 529 | 467 | 670 | 499 | 492 | 449 | 898 | 375 | 335 | 362 |
| Operating Income
| 390 | 386 | 414 | 312 | 0.232 | 0.389 | 331 | 227 | 358 | 432 | 486 | 334 | 394 | 458 | 466 | 465 | 703 | 731 | 880 |
| Operating Income Ratio
| 0.247 | 0.24 | 0.255 | 0.195 | 0 | 0 | 0.215 | 0.153 | 0.233 | 0.273 | 0.31 | 0.208 | 0.246 | 0.287 | 0.309 | 0.146 | 0.436 | 0.479 | 0.494 |
| Total Other Income Expenses Net
| -183 | -151 | -178 | -208 | -152 | -135 | -159 | -168 | -137 | -181 | -97 | -98 | -128 | -21 | 1 | -12 | -22 | -29 | -36 |
| Income Before Tax
| 207 | 235 | 236 | 104 | 80 | 254 | 235 | 111 | 282 | 287 | 442 | 236 | 389 | 437 | 467 | 453 | 681 | 702 | 844 |
| Income Before Tax Ratio
| 0.131 | 0.146 | 0.145 | 0.065 | 0.053 | 0.158 | 0.153 | 0.075 | 0.183 | 0.181 | 0.282 | 0.147 | 0.243 | 0.274 | 0.31 | 0.143 | 0.422 | 0.46 | 0.474 |
| Income Tax Expense
| -152 | 40 | 35 | -442 | 22 | 12 | 58 | 3 | 55 | 53 | 94 | 34 | 66 | 6 | 72 | 173 | 121 | 116 | 110 |
| Net Income
| 359 | 195 | 201 | 546 | 58 | 242 | 177 | 108 | 227 | 234 | 348 | 202 | 323 | 427 | 399 | 368 | 547 | 542 | 703 |
| Net Income Ratio
| 0.227 | 0.121 | 0.124 | 0.342 | 0.038 | 0.15 | 0.115 | 0.073 | 0.148 | 0.148 | 0.222 | 0.126 | 0.202 | 0.268 | 0.265 | 0.116 | 0.339 | 0.355 | 0.395 |
| EPS
| 1.39 | 0.76 | 0.79 | 2.14 | 0.23 | 0.95 | 0.7 | 0.42 | 0.89 | 0.92 | 1.37 | 0.8 | 1.27 | 1.68 | 1.58 | 1.45 | 2.16 | 2.14 | 2.78 |
| EPS Diluted
| 1.38 | 0.75 | 0.78 | 2.13 | 0.23 | 0.95 | 0.69 | 0.42 | 0.89 | 0.92 | 1.36 | 0.79 | 1.27 | 1.68 | 1.58 | 1.45 | 2.16 | 2.14 | 2.78 |
| EBITDA
| 402 | 432 | 479 | 374 | 293 | 447 | 451 | 279 | 476 | 518 | 592 | 396 | 569 | 563 | 504 | 509 | 743 | 765 | 938 |
| EBITDA Ratio
| 0.254 | 0.281 | 0.295 | 0.232 | 0.15 | 0.241 | 0.252 | 0.188 | 0.27 | 0.304 | 0.344 | 0.209 | 0.308 | 0.327 | 0.333 | 0.182 | 0.466 | 0.509 | 0.527 |